4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5
INDUSTRY TRENDS
Captures industry movement, adoption patterns, and strategic signals across key end-use segments and regions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL MEDICAL SUPPLIES MARKET INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF MEDICAL SUPPLIES PRODUCTS, BY KEY PLAYER, 2024-2026
5.6.2
AVERAGE SELLING PRICE TREND OF MEDICAL SUPPLIES PRODUCTS, BY REGION, 2024-2026
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFF – MEDICAL SUPPLIES MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES/REGIONS
5.12.5
IMPACT ON END USERS
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY/EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON MEDICAL SUPPLIES MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES FOLLOWED BY MANUFACTURERS IN MEDICAL SUPPLIES MARKET
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL SUPPLIES MARKET
6.6.4
INTERCONNECTED/ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICAL SUPPLIES MARKET
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN MEDICAL SUPPLIES MARKET MARKET
7.2.2
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.3
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4
UNMET NEEDS OF VARIOUS END USERS
9
MEDICAL SUPPLIES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
9.2.1
BLOOD COLLECTION CONSUMABLES
9.2.1.1
BLOOD COLLECTION TUBES
9.2.1.2
NEEDLES & SYRINGES
9.2.2
OTHER SAMPLE COLLECTION CONSUMABLES
9.3.1
PERITONEAL DIALYSIS CONSUMABLES
9.3.2
HEMODIALYSIS CONSUMABLES
9.4
WOUND CARE CONSUMABLES
9.4.1
ADVANCED WOUND DRESSINGS
9.4.2
TRADITIONAL WOUND CARE
9.5
RADIOLOGY CONSUMABLES
9.9.3
SURFACE DISINFECTANTS
9.9.4
INSTRUMENT DISINFECTANTS
9.7
INFUSION & INJECTABLE SUPPLIES
9.8
INTUBATION & VENTILATION SUPPLIES
9.9
PERSONAL PROTECTIVE EQUIPMENT (PPE)
9.9.1
HAND & ARM PROTECTIVE EQUIPMENT
9.9.2
EYE & FACE PROTECTIVE EQUIPMENT
9.9.3
PROTECTIVE CLOTHING
9.9.4
FOOT & LEG PROTECTIVE EQUIPMENT
9.9.5
RESPIRATORY PROTECTION
9.9.6
OTHER PROTECTIVE EQUIPMENT
9.10
STERILIZATION CONSUMABLES
9.11.1
CARDIOVASCULAR CATHETERS
9.11.2
INTRAVENOUS CATHETERS
9.11.3
UROLOGICAL CATHETERS
9.11.4
SPECIALTY CATHETERS
9.11.5
NEUROVASCULAR CATHETERS
9.12
SLEEP APNEA SUPPLIES
9.13.6
PROCEDURE KITS/TRAYS
9.13.7
OTHER SURGICAL SUPPLIES
9.14
OTHER MEDICAL SUPPLIES
10
MEDICAL SUPPLIES MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
10.9
IN VITRO DIAGNOSTICS (IVD)
11
MEDICAL SUPPLIES MARKET, BY CLASS OF MEDICAL DEVICE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
12
MEDICAL SUPPLIES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
12.2
CLINICS / PHYSICIAN OFFICES
13
MEDICAL SUPPLIES MARKET ,BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
13.4.4
REST OF ASIA PACIFIC
13.6
MIDDLE EAST & AFRICA
14.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
14.3
REVENUE ANALYSIS 2023-2025
14.3.1
MARKET SHARE ANALYSIS,
14.3.1.1
GLOBAL MARKET SHARE ANALYSIS
14.3.1.2
US MARKET SHARE ANALYSIS
14.3.3
COMPANY EVALUATION MATRIX: KEY PLAYERS,
14.3.3.2
EMERGING LEADERS
14.3.3.3
PERVASIVE PLAYERS
14.3.3.5
COMPANY FOOTPRINT: KEY PLAYERS,
14.3.3.5.1
COMPANY FOOTPRINT
14.3.3.5.2
REGION FOOTPRINT
14.3.3.5.3
TYPE FOOTPRINT
14.3.3.5.4
APPLICATION FOOTPRINT
14.3.3.5.5
WOUND TYPE FOOTPRINT
14.3.4
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
14.3.4.1
PROGRESSIVE COMPANIES
14.3.4.2
RESPONSIVE COMPANIES
14.3.4.3
DYNAMIC COMPANIES
14.3.4.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
14.3.4.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.3.4.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
14.3.5
COMPANY VALUATION AND FINANCIAL METRICS
14.3.6
COMPETITIVE SCENARIO
14.3.9.1
PRODUCT LAUNCHES
15.1.4
JOHNSON & JOHNSON PRIVATE
15.1.5
B. BRAUN MELSUNGEN AG
15.1.6
BOSTON SCIENTIFIC CORPORATION
15.1.7
THERMO FISHER SCIENTIFIC
15.1.13
MERIT MEDICAL SYSTEMS
15.1.15
TERUMO CORPORATION
15.1.16
TELEFLEX INCORPORATED
15.2.1
FRESENIUS MEDICAL CARE
15.2.5
MEDLINE INDUSTRIES, LP
15.2.6
DEROYAL INDUSTRIES, INC.
15.2.8
SHENZHEN MEDRENA BIOTECH CO.,
15.2.10
INVACARE CORPORATION.
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.1.2
LIST OF KEY SECONDARY SOURCES
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
16.1.2.2
KEY PRIMARY PARTICIPANTS
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
16.1.2.4
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
BOTTOM-UP APPROACH
16.2.3
MARKET SIZE CALCULATION FOR BASE YEAR
16.3
MARKET FORECAST APPROACH
16.6
RESEARCH ASSUMPTIONS
16.7
RESEARCH LIMITATIONS
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Medical Supplies Market